/>

Wednesday, October 24, 2018

NEWS 24 OCT 2018

NEWS FROM USA

NDA Approvals        

Approval Date

Drug

NDA Sponsor

Brand Name

Prescribing information

19 Oct 2018

Levoleucovorin Injection

Spectrum Pharms

Khapzory

Link

Earlier approved Levoleucovorin was calcium salt

 

ANDA Approvals 

 

Approval Date

Drug Product

ANDA

Sponsor

Corresponding RLD

Number Of Other Approved Generics

17 Oct 2018

Lansoprazole Dr Capsule

Breckenridge Pharm

Prevacid (Takeda)

Thirteen

17 Oct 2018

Adapalene; Benzoyl Peroxide Topical Gel

Taro

Epiduo Forte (Galderma)

None

17 Oct 2018

Cefazolin Sodium Injection

Qilu Pharm 

N/A

Five

17 Oct 2018

Ceftriaxone Sodium Injection

Qilu Pharm 

N/A

Six

17 Oct 2018

Isoproterenol Hydrochloride Injection

Amneal Pharms 

Isuprel (Hospira)

Three

18 Oct 2018

Capreomycin Sulfate Injection

Hisun Pharm 

Capastat Sulfate (Akorn)

One (Mylan)

18 Oct 2018

Acetazolamide Er Capsule

Accord Hlthcare

Diamox (Teva)

Four

18 Oct 2018

Norepinephrine Bitartrate Injection

Sandoz

Levophed (Hospira)

Four

20 Oct 2018

Gabapentin Capsule

Strides

Neurontin (Pfizer)

Fifteen

22 Oct 2018

Clobazam Tablets

West-Ward Pharma

Onfi (Lundbeck)

All the generics were approved on the same date as Onfi’s ODE expired on 21 Oct 2018

Eight

22 Oct 2018

Clobazam Suspension

Bionpharma 

Four

22 Oct 2018

Clobazam Tablets

Bionpharma 

Eight

22 Oct 2018

Clobazam Tablets

Breckenridge  

Eight

22 Oct 2018

Clobazam Tablets

Taro Pharm

Eight

22 Oct 2018

Clobazam Tablets

Upsher-Smith 

Eight

22 Oct 2018

Clobazam Suspension

West-Ward 

Four

22 Oct 2018

Clobazam Tablets

Amneal 

Eight

22 Oct 2018

Clobazam Tablets

Hetero Labs  

Eight

22 Oct 2018

Clobazam Tablets

Piramal 

Eight

22 Oct 2018

Clobazam Suspension

Amneal 

Four

22 Oct 2018

Clobazam Suspension

Upsher

Four

22 Oct 2018

Clobazam Suspension

Mylan 

Four

22 Oct 2018

Clobazam Tablets

Zydus 

Eight

22 Oct 2018

Triamcinolone Acetonide Ointment 

Lupin

Triamcinolone Acetonide Ointment (Mylan)

Eleven

*Highlighted products are the 1st generics approval for the corresponding RLD

 

Tentative ANDA Approvals           

Approval Date

Drug

Company

12 Oct 2018

Alogliptin

Alembic

12 Oct 2018

Mifepristone

Teva

15 Oct 2018

Benzoyl Peroxide;Clindamycin Phosphate

Tolmar

16 Oct 2018

Fesoterodine Fumarate

Torrent

16 Oct 2018

Colchicine

Zydus

19 Oct 2018

Tadalafil

Amneal 

 

NEW GENERICS LAUNCHES IN US

 

DRUG

COMPANY

Corresponding RLD

Annual sales quoted in press release as per IQVIA

Press Release

Medroxyprogesterone Acetate Injectable Suspension 

Mylan

Depo-Provera (Pfizer)

$ 181 Million

Link

Isoproterenol Hydrochloride

Amneal

Isuprel (HOSPIRA )

$158 Million

Link

Carmustine

Amneal

BiCNU (Emcure)

$84 Million

Link

Clobazam Tablets

Amneal

Onfi (Lundbeck)

$594 Million

Link

Clobazam Tablets

Camber (Hetero)

Onfi (Lundbeck)

$594 Million

Link

Clobazam Tablets

Bionpharma

Onfi (Lundbeck)

$594 Million

Link

Clobazam Suspension

Amneal

Onfi (Lundbeck)

$255 Million

Link

Clobazam Suspension

Bion pharma

Onfi (Lundbeck)

$255 Million

Link

 

USFDA INSPECTION

Lupin's Pithampur Unit-3 (Indore) Inspected by US FDA

 

NEWS FROM EUROPE

Positive CHMP opinions (EMA)

Drug

Sponsor

Indication

Mexiletine Hydrochloride

Lupin

Myotonia In Non-Dystrophic Myotonic Disorders

Ivacaftor

Vertex Pharma

Treat Patients With Cystic Fibrosis Aged 12 to <24 Months

 

Other News from Europe

·         Mylan and Biocon Announce Positive CHMP Opinion for Ogivri, Biosimilar Trastuzumab 

·         Mylan Launches Hulio (Biosimilar Adalimumab) in Markets Across Europe

 

Now, you can also follow us on twitter @pharmacaptions. If you have any query/suggestion then please write us at pharmacaption@gmail.com

                                                                                                                     

 

 

 

                                                                

No comments:

Post a Comment